Home » Topics » Disease categories and therapies » Musculoskeletal

Musculoskeletal
RSS

Roche commences phase II trial of RO-7123520 in moderate to severely active rheumatoid arthritis

Jan. 3, 2017

Medshine Discovery discloses JAK inhibitors

Dec. 29, 2016

Pharmacyclics patents BTK inhibitors

Dec. 28, 2016

EMA committee recommends approval of baricitinib for RA

Dec. 19, 2016

EMA grants orphan designation to REGN-2477 for fibrodysplasia ossificans progressiva

Dec. 16, 2016

OrthoTrophix's TPX-100 improves knee function in phase II study in knee osteoarthritis

Dec. 16, 2016

FDA approves MACI to repair knee cartilage defects

Dec. 14, 2016

University of Michigan discloses cyclic peptides

Dec. 13, 2016

Flexion Therapeutics submits NDA to FDA for Zilretta

Dec. 13, 2016

New U.K. alliance established to accelerate development of treatments for arthritis

Dec. 12, 2016

Popular Stories

News in brief
BioWorld Asia
BioWorld Asia briefs for April 28, 2026
Bio Korea 2026 kicks off with spotlight on oligonucleotides
BioWorld
Three decades of trial-and-error, and the resulting safety data, in the oligonucleotide-based therapeutic space have paved way for the present-day innovations and...
Chinese biotechs gain leverage as partners in dealmaking
BioWorld
China’s biotech ecosystem has crossed an inflection point, and Chinese biotechs are gaining leverage in dealmaking, executives from multinational companies said...
University of Western Australia patents 5-HT2A/B modulators
BioWorld Science
University of Western Australia has identified new lysergic acid diethylamide (LSD) analogues acting as 5-HT2A and 5-HT2B modulators reported to be useful for the...
AA meeting of minds as PTC, Novartis push votoplam in HD
BioWorld
What PTC Therapeutics Inc.’s latest data with votoplam might mean in the Huntington’s disease (HD) landscape became grist for Wall Street after the firm unveiled...